Replies to post #102170 on Biotech Values

[DFRAI]

Regulardoc - thanks for the info . Scripts info anyone? it seems
that the price wars have started in earnest - wonder how much sense it will make for TEVA to enter the market given the actions by Sanofi.

i am sure that those with access to better information used the opportunity to short the approval and are now covering as a bottom is forming in the stock.

[jbog]

Finally, something that has not been reported, and probably is not a major issue, except for initial selling of the drug and "first impressions" is that Sandoz has had a few instances in which the prefilled syringe spring mechanism did not work properly


http://www.ismp.org/newsletters/acutecare/articles/20100812.asp

[dewophile]

lovenox pricing

i find it amazing SNY negotiated a discount just in time for the generic approval whose timing no one predicted
and 40% doesn't make sense - it is in no one's interest (and is not consistent with the hit SNY told the street they would take from introduction of a generic). so if what you say is true it cannot be happening on a wide scale

[DewDiligence]

Thanks, Regulardoc. NVS may have made a decision not to compete for the VA business, which (along with so-called 340B institutions) is the least profitable part of the hospital universe for drug companies.

--
Do you have rough numbers on the proportion of hospital usage of each the seven Lovenox doses that come in a prefilled syringe? T.i.a. Dew

[Rocky3]

On that subject, for VHA contracts, SNY dropped the price of Lovenox by 40% in July. I believe this is way more aggressive than Sandoz expected and is probably behind the continual drop in the stock, as I believe the legal issues pose minimal risk.

As I have said, I agree that revenue uncertainty is the number one reason for the price drop. The market needs to see actual sales numbers. I am optimistic that the numbers will be good, but I could easily be wrong. I have asked a couple sources for script numbers, but have not gotten anything yet (other than first week numbers that showed almost 0 sales).

I was expecting a decision before market open today, so I am very disappointed in market price right now.